revumenib,ziftomenib
syndax pharma,kura oncology
[]
 it's been a long #ash22 already...
Journalist at Evaluate Vantage. Proudly blocked by @JohnCendpts. Interested in: oncology, immunology. Not interested in: what stock you bought today.